Formation Bio logo

Formation Bio

Challenger

Formation Bio is an AI-native pharmaceutical company that acquires clinical-stage drug assets and accelerates their development to market using proprietary AI and operational technology; raised $372M in a 2024 Series D;

Best for: AI-Native Drug Development & Clinical Asset Acceleration
53
AI Score
Grade C
AI Visibility Score (Beta)
Life Sciences & BioTechAI-Native Drug Development & Clinical Asset AccelerationWebsiteUpdated October 2026

Company Overview

About Formation Bio

Formation Bio (formerly TrialSpark) is a New York-based AI-native pharmaceutical company founded in 2016 by Nicky Popp and Benjamine Liu. The company operates at the intersection of artificial intelligence and drug development, acquiring clinical-stage pharmaceutical assets — compounds that have demonstrated early safety and efficacy in human trials — and applying proprietary AI and operational technology to accelerate their development timelines and reduce costs. Rather than discovering new drug targets from scratch, Formation Bio's model focuses on execution excellence: identifying undervalued clinical assets and getting them to patients faster and more cheaply than traditional pharma development organizations can.

Business Model & Competitive Advantage

Formation Bio's technology platform encompasses AI-assisted clinical trial design and execution, patient recruitment optimization, site selection algorithms, and regulatory strategy tools. Its operational approach integrates these AI capabilities with a multidisciplinary in-house team of pharma veterans, data scientists, and engineers who manage clinical programs end-to-end. The company originally operated under the name TrialSpark, focused primarily on making clinical trials faster through decentralized and site optimization approaches, before pivoting to its current asset acquisition and AI-powered development model under the Formation Bio brand.

Competitive Landscape 2025–2026

The company raised a $372M Series D in 2024, bringing total funding to over $600M, from investors including a16z Bio, 8VC, and Sequoia Capital, among others. Formation Bio also entered a significant partnership with Pfizer — a $100M+ collaboration — to co-develop select clinical-stage assets using Formation Bio's AI and development capabilities alongside Pfizer's resources. This big-pharma validation partnership represents a key milestone, positioning Formation Bio not just as an independent drug developer but as a platform that major pharmaceutical companies can engage to accelerate their own pipelines.

Founded
2016
Curated content • Fact-checked and verified

Key Differentiators

Strong Challenger

Formation Bio is an established challenger with significant market presence and competitive offerings in Life Sciences & BioTech.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

53
→ Stable

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Emulate logo

Emulate

Life Sciences & BioTech
HealthtechB2bEnterpriseAi PoweredHardwarePlatformStartupScaleupGlobalNorth America

Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m

ConcertAI logo

ConcertAI

Life Sciences & BioTech
HealthtechAi PoweredAnalyticsB2bSaasEnterpriseData WarehousePlatformUnicorn

ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult

Neuralink logo

Neuralink

Life Sciences & BioTech
HealthtechHardwareAi PoweredB2b2cStartupDecacornNorth AmericaTechnologyPlatformEnterprise

Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa

DNAnexus logo

DNAnexus

Life Sciences & BioTech
B2bSaasHealthtechCloud NativeAnalyticsEnterprisePlatformGlobalAi PoweredInfrastructure

DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a

Tempus logo

Tempus

Life Sciences & BioTech
HealthtechB2bAi PoweredAnalyticsPlatformPublicSaasTechnologyNorth America

Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o

Schrödinger logo

Schrödinger

Life Sciences & BioTech
B2bGlobalPublicEnterpriseHealthtechAi PoweredSaasPlatformAnalytics

Schrödinger was founded in 1990 by Richard Friesner and David Pearlman in New York City, building physics-based computational methods for molecular simulation. For over 30 years the company has develo

Compare Formation Bio with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For Formation Bio

Claim This Profile

Are you from Formation Bio? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Formation Bio Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Formation Bio vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →